AMA CPT® Assistant - 2021 Issue 3 (March)
Reporting Intrathecal Injection of Nusinersen (March 2021)
March 2021 page 3 Reporting Intrathecal Injection of Nusinersen Over the past several years, numerous inquiries have been received via the American Medical Association’s (AMA’s) Current Procedural Terminology (CPT®) Network regarding appropriate reporting of intrathecal injections of nusinersen, a complex biological drug used to treat spinal muscular atrophy (SMA). This article discusses the appropriate coding and reporting of this service. Use of Nusinersen for Patients With SMA SMA patients have a genetically defective or missing SMN1 gene, which is responsible for the majority of survival motor neuron (SMN) protein production and is necessary to prevent neuron cell death...
Subscribe or sign in to view the full article.
Article Overview
This CPT Assistant article reviews coding guidance for intrathecal injection of nusinersen for spinal muscular atrophy. It explains why the topic generated conflicting reporting advice, summarizes the consensus process behind the guidance, and discusses the general categories of CPT and HCPCS reporting involved. The article is relevant to coders, billers, and other professionals responsible for accurately reporting biologic drug administration services.
Why This Topic Matters
Accurate reporting of nusinersen administration affects how complex intrathecal drug delivery services are coded and supported in claims workflows. The article helps readers understand the official CPT-oriented guidance and the related role of imaging and supply reporting.
Article Sections
-
March 2021 page 3
Administrative page reference and article placement information.
-
Reporting Intrathecal Injection of Nusinersen
Overview of the reporting issue and the clinical service being discussed.
-
Use of Nusinersen for Patients With SMA
Background on the medication, the condition it is used for, and the general clinical context of the therapy.
-
Developing Coding Guidance
Discussion of the published guidance, stakeholder involvement, and the coding framework used to resolve the reporting question.
What You Will Learn
- The clinical and coding context for intrathecal nusinersen administration
- How the article frames the role of CPT and HCPCS guidance in reporting
- Which types of related services may be discussed alongside the primary administration service
- Why the topic drew conflicting advice in the coding literature
Who Should Read This
- Medical coders
- Coding managers
- Billers and revenue cycle staff
- Compliance professionals
- Physician practice administrators
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com